RCM

RA Capital Management Portfolio holdings

AUM $5.94B
1-Year Est. Return 18.15%
This Quarter Est. Return
1 Year Est. Return
+18.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$6.4B
AUM Growth
+$1.32B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
71
New
Increased
Reduced
Closed

Top Buys

1
+$309M
2
+$35.7M
3
+$27.6M
4
URGN icon
UroGen Pharma
URGN
+$24M
5
GPCR icon
Structure Therapeutics
GPCR
+$19.8M

Top Sells

1
+$77.1M
2
+$62.6M
3
+$36.6M
4
RNA icon
Avidity Biosciences
RNA
+$35.9M
5
CVAC icon
CureVac
CVAC
+$33.1M

Sector Composition

1 Healthcare 99.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
1
$1.27B 19.88%
10,107,400
-612,155
2
$704M 11%
23,750,601
+10,428,313
3
$496M 7.74%
7,891,254
4
$377M 5.89%
6,264,707
5
$245M 3.83%
5,330,412
-345,655
6
$187M 2.92%
236,114
7
$180M 2.8%
4,724,207
8
$164M 2.56%
6,940,000
9
$138M 2.15%
532,892
10
$137M 2.14%
3,404,285
+351,489
11
$128M 1.99%
11,416,948
12
$126M 1.96%
6,317,990
13
$114M 1.78%
7,809,852
14
$114M 1.78%
5,551,295
15
$100M 1.57%
7,236,454
16
$98.3M 1.54%
9,165,652
17
$97.5M 1.52%
46,202,425
18
$94M 1.47%
5,963,565
19
$93.6M 1.46%
4,909,763
+218,585
20
$91.9M 1.44%
18,202,009
+1,000,000
21
$87.8M 1.37%
7,864,000
-1,136,000
22
$84.3M 1.32%
4,163,211
23
$84.2M 1.32%
2,549,132
-187,548
24
$79.6M 1.24%
1,000,000
25
$78.4M 1.22%
11,609,704
1
2 3